Breaking News Instant updates and real-time market news.

TNDM

TNDM

16:29
11/04/19
11/04
16:29
11/04/19
16:29

Tandem Diabetes reports Q3 EPS (9c), consensus (20c)

Reports Q3 revenue $94.7M, consensus $89.14M. Reports Q3 Adjusted EBITDA margin 13% vs. 10% last year. As of September 30, 2019, the company had $156.9M in cash, cash equivalents and short-term investments. This represents a $25.6M increase in the third quarter of 2019 and a $27.9M increase since December 31, 2018. CEO John Sheridan says: "Our third quarter results once again demonstrate that technology drives customer adoption, and that there is meaningful long-term opportunity to continue bringing the benefits of insulin pump therapy to people with diabetes worldwide. With approval of the t:slim X2 insulin pump with Control-IQ technology pending, we're positioned for an exciting end of 2019 and beyond as we work to continue driving growth through innovation and further our mission to improve the lives of people with diabetes."

  • 04

    Nov

  • 14

    Nov

TNDM TNDM

10/15/19
OPCO
10/15/19
NO CHANGE
OPCO
Outperform
DexCom should be bought after 'negative' Tandem headline, says Oppenheimer
Oppenheimer analyst Steven Lichtman said Tandem Diabetes' (TNDM) announcement that it is exploring integrated solutions with Abbott (ABT) is a potential long-term positive as integration with the latter's Libre system would expand the former's reach with patients. While a "negative headline" for DexCom (DXCM), he would be a buyer on weakness, arguing that it is still early in the process and DexCom "continues to march forward toward" G-7, with a limited launch of the CGM expected in late 2020. Lichtman has Outperform ratings on both Tandem and DexCom.
10/17/19
LSCM
10/17/19
NO CHANGE
Target $100
LSCM
Buy
Tandem Diabetes partnership offers 'substantial opportunity,' says Lake Street
Lake Street analyst Brooks O'Neil believes Tandem Diabetes' (TNDM) partnership with Abbott (ABT) offers the company "substantial opportunity." Abbott's Libre opens a "huge incremental opportunity" for Tandem both in the U.S. and around the world, O'Neil tells investors in a research note. In addition, the deal likely opens the "door wide" for further positive reimbursement decisions for Tandem, contends the analyst. He keeps a Buy rating on Tandem Diabetes with a $100 price target.
10/17/19
GUGG
10/17/19
INITIATION
Target $76
GUGG
Buy
Tandem Diabetes initiated with a Buy at Guggenheim
Guggenheim analyst Chris Pasquale initiated coverage of Tandem Diabetes with a Buy rating and $76 price target.
10/17/19
GUGG
10/17/19
INITIATION
Target $76
GUGG
Buy
Guggenheim starts 'remarkable' turnaround story Tandem Diabetes with Buy
Guggenheim analyst Chris Pasquale initiated coverage of Tandem Diabetes with a Buy rating and $76 price target. The analyst views the company as a "remarkable MedTech turnaround story." Management has successfully guided the company from a going concern risk at the start of 2018 to an over $4B market cap a year later, Pasquale tells investors in a research note. He sees the 19% pullback in the shares since March as creating an attractive entry point. The stock's current valuation is more than supported by Tandem's long-term growth outlook, and the upcoming Control-IQ launch representing an important near-term catalyst, says the analyst.

TODAY'S FREE FLY STORIES

ALGT

Allegiant Travel

$172.80

0.57 (0.33%)

11:06
12/11/19
12/11
11:06
12/11/19
11:06
Hot Stocks
Allegiant Travel reports November scheduled service RPMs up 1.6% »

Allegiant Travel reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$251.05

-0.74 (-0.29%)

11:05
12/11/19
12/11
11:05
12/11/19
11:05
Hot Stocks
Huntington Ingalls appoints Bharat Amin as EVP, CIO »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$35.35

0.65 (1.87%)

11:05
12/11/19
12/11
11:05
12/11/19
11:05
Options
Ciena call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMZN

Amazon.com

$1,738.75

-0.4 (-0.02%)

11:01
12/11/19
12/11
11:01
12/11/19
11:01
Periodicals
Alexa devices sell out in parts of Europe before Christmas, Bloomberg reports »

Amazon's new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVER

EverQuote

$34.09

-1.95 (-5.41%)

11:01
12/11/19
12/11
11:01
12/11/19
11:01
On The Fly
EverQuote down after Bonitas says it expects stock to drop to about $5 »

Shares of EverQuote…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
12/11/19
12/11
11:01
12/11/19
11:01
Conference/Events
JPMorgan banking analyst to hold an analyst/industry conference call »

U.S. Mid & Small Cap…

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:59
12/11/19
12/11
10:59
12/11/19
10:59
Hot Stocks
Breaking Hot Stocks news story on LogMeln 

LogMein trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:58
12/11/19
12/11
10:58
12/11/19
10:58
Hot Stocks
LogMeln up 6% after report of private equity takeover talks »

Shares of LogMeIn are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Periodicals
PE firms in talks to buy LogMeln, Bloomberg says »

Francisco Partners and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDC

SmileDirectClub

$7.89

-0.06 (-0.75%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Options
SmileDirectClub put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWI

SolarWinds

$18.07

-0.11 (-0.61%)

10:55
12/11/19
12/11
10:55
12/11/19
10:55
Conference/Events
SolarWinds to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LOGM

LogMeln

$74.20

0.24 (0.32%)

10:54
12/11/19
12/11
10:54
12/11/19
10:54
Hot Stocks
Breaking Hot Stocks news story on LogMeln »

LogMein trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

10:53
12/11/19
12/11
10:53
12/11/19
10:53
Syndicate
Breaking Syndicate news story on XP »

XP indicated to open at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MNST

Monster Beverage

$62.03

0.51 (0.83%)

10:45
12/11/19
12/11
10:45
12/11/19
10:45
Options
Monster Beverage call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/11/19
12/11
10:45
12/11/19
10:45
General news
Energy Action: WTI crude »

Energy Action: WTI crude…

CI

Cigna

$190.86

-0.88 (-0.46%)

, CVS

CVS Health

$73.06

-0.11 (-0.15%)

10:42
12/11/19
12/11
10:42
12/11/19
10:42
On The Fly
Cigna downgrade, Apple, PC&G target raises among today's top calls »

Check out today's top…

CI

Cigna

$190.86

-0.88 (-0.46%)

CVS

CVS Health

$73.06

-0.11 (-0.15%)

AMZN

Amazon.com

$1,740.89

1.74 (0.10%)

NFLX

Netflix

$298.30

5.09 (1.74%)

UPS

UPS

$117.55

-0.94 (-0.79%)

PCG

PG&E

$12.94

0.61 (4.95%)

AAPL

Apple

$270.44

1.82 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 06

    Feb

ALKS

Alkermes

$21.49

-0.08 (-0.37%)

10:40
12/11/19
12/11
10:40
12/11/19
10:40
Hot Stocks
FDA issues warning letter to Alkermes over print ad for Vivitrol »

In a warning letter dated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLOK

NortonLifeLock

$26.39

0.1 (0.38%)

10:35
12/11/19
12/11
10:35
12/11/19
10:35
Options
NortonLifeLock put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

EVER

EverQuote

$35.00

-1.04 (-2.89%)

10:33
12/11/19
12/11
10:33
12/11/19
10:33
Periodicals
EverQuote named as short idea by Bonitas Research 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

10:30
12/11/19
12/11
10:30
12/11/19
10:30
Syndicate
Breaking Syndicate news story on XP »

XP indicated to open at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

USO

United States Oil Fund

$12.35

-0.04 (-0.32%)

10:30
12/11/19
12/11
10:30
12/11/19
10:30
General news
Crude inventories for week of December 6 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$191.14

-0.6 (-0.31%)

, MET

MetLife

$49.25

-0.04 (-0.08%)

10:28
12/11/19
12/11
10:28
12/11/19
10:28
On The Fly
Street Fight: Cigna sparks analyst debate over PillPack news, possible unit sale »

Shares of Cigna (CI) are…

CI

Cigna

$191.14

-0.6 (-0.31%)

MET

MetLife

$49.25

-0.04 (-0.08%)

SLF

Sun Life Financial

$44.82

0.04 (0.09%)

WBA

Walgreens Boots Alliance

$57.92

-0.48 (-0.82%)

WCG

WellCare

$317.16

-2.3 (-0.72%)

ACHC

Acadia

$31.73

-0.37 (-1.15%)

EHC

Encompass Health

$70.90

-0.88 (-1.23%)

ANTM

Anthem

$281.14

-2.45 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 08

    Jan

  • 06

    Feb

  • 13

    Feb

XP

XP

$0.00

(0.00%)

10:24
12/11/19
12/11
10:24
12/11/19
10:24
Syndicate
XP indicated to open at $34.00, IPO priced at $27.00 »

XP (XP) priced 72.5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

10:22
12/11/19
12/11
10:22
12/11/19
10:22
Conference/Events
JPMorgan healthcare tech analyst to hold an analyst/industry conference call »

Healthcare Technology…

F

Ford

$9.12

0.045 (0.50%)

10:20
12/11/19
12/11
10:20
12/11/19
10:20
Options
Long-dated put sale in Ford sold tied to hedge possibly closes »

Long-dated put sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 04

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.